Brazilian healthcare system seeks diagnostic support from private firms as a part of healthcare improvisation
The Brazilian government has lined up plans to engage the services of a private medtech company for improvisation of diagnosis and treatment of the heart–care patients in the state-sponsored hospitals. Medtronic recognizes this as an opportunity. Medtronic after the acquisition of Covidien has combined both low and high priced medical devices for cardiac patients, thereby providing inventory management across the hospital. The company plans to position itself as an entire cabinet supplier for complex devices used in cardiac surgeries.
(Image courtesy: Omnicell)
Read the full article at StarTribune